Silexion Therapeutics Corp
SLXN
$3.78
$0.051.34%
NASDAQ
12/31/2024 | 09/30/2024 | 03/31/2024 | 12/31/2023 | ||
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.19M | 1.97M | 2.78M | 4.60M | |
Total Receivables | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | |
Prepaid Expenses | 966.00K | 944.00K | 465.00K | 335.00K | |
Finance Division Loans and Leases Current | -- | -- | -- | -- | |
Total Finance Division Other Current Assets | -- | -- | -- | -- | |
Other Current Assets | 97.00K | 130.00K | 93.00K | 49.00K | |
Total Current Assets | 2.25M | 3.05M | 3.34M | 4.98M | |
|
|||||
Total Current Assets | 2.25M | 3.05M | 3.34M | 4.98M | |
Net Property, Plant & Equipment | 560.00K | 35.00K | 216.00K | 247.00K | |
Long-term Investments | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | |
Total Other Intangibles | -- | -- | -- | -- | |
Finance Div Loans & Leases LT | -- | -- | -- | -- | |
Total Finance Div Other LT Assets | -- | -- | -- | -- | |
Total Other Assets | 53.00K | 5.00K | 30.00K | 30.00K | |
Total Assets | 2.86M | 3.09M | 3.59M | 5.26M | |
|
|||||
Total Accounts Payable | 929.00K | 799.00K | 244.00K | 319.00K | |
Total Accrued Expenses | 1.43M | 2.55M | 1.31M | 1.57M | |
Short-term Debt | 1.00M | 229.00K | -- | -- | |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
Finance Division Debt Current | 158.00K | -- | 110.00K | 112.00K | |
Total Finance Division Other Current Liabilities | 2.00K | 10.00K | 281.00K | 200.00K | |
Total Other Current Liabilities | 2.00K | 10.00K | 281.00K | 200.00K | |
Total Current Liabilities | 3.52M | 3.58M | 1.94M | 2.20M | |
|
|||||
Total Current Liabilities | 3.52M | 3.58M | 1.94M | 2.20M | |
Long-Term Debt | 2.96M | -- | -- | -- | |
Short-term Debt | 1.00M | 229.00K | -- | -- | |
Capital Leases | 368.00K | -- | 34.00K | 59.00K | |
Finance Division Debt Non Current | -- | -- | -- | -- | |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
Total Other Liabilities | -- | 4.08M | -- | -- | |
Total Liabilities | 6.85M | 7.67M | 1.98M | 2.26M | |
|
|||||
Common Stock & APIC | 39.27M | 37.00M | 11.37M | 11.34M | |
Retained Earnings | -43.25M | -41.58M | -28.18M | -26.81M | |
Treasury Stock & Other | -- | -- | -- | -- | |
Total Common Equity | -3.99M | -4.58M | -16.82M | -15.48M | |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | |
Preferred Stock Non Redeemable | -- | -- | -- | -- | |
Preferred Stock Convertible | -- | -- | 15.06M | 15.06M | |
Preferred Stock, Others | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | 15.06M | 15.06M | |
|
|||||
Total Common Equity | -3.99M | -4.58M | -16.82M | -15.48M | |
Total Preferred Equity | -- | -- | 15.06M | 15.06M | |
Total Minority Interest | -- | -- | 3.37M | 3.42M | |
Total Equity | -3.99M | -4.58M | 1.61M | 3.00M | |
|